Advanced company searchLink opens in new window

IKSUDA THERAPEUTICS LIMITED

Company number 06433234

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
09 Sep 2021 SH08 Change of share class name or designation
03 Sep 2021 SH01 Statement of capital following an allotment of shares on 25 August 2021
  • GBP 4,031.786
03 Sep 2021 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
19 Aug 2021 AA01 Previous accounting period shortened from 31 December 2021 to 31 July 2021
03 Aug 2021 AA01 Current accounting period extended from 31 July 2021 to 31 December 2021
15 Jun 2021 PSC08 Notification of a person with significant control statement
15 Jun 2021 SH01 Statement of capital following an allotment of shares on 1 June 2021
  • GBP 3,694.935
15 Jun 2021 MA Memorandum and Articles of Association
15 Jun 2021 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
01 Jun 2021 TM01 Termination of appointment of Michael John Owen as a director on 1 June 2021
01 Jun 2021 TM01 Termination of appointment of Alan Peter Mackenzie Lamb as a director on 1 June 2021
01 Jun 2021 TM01 Termination of appointment of William Taninhill Blair as a director on 1 June 2021
01 Jun 2021 AP01 Appointment of Jinseok Seo as a director on 1 June 2021
01 Jun 2021 PSC07 Cessation of Ip2Ipo Limited as a person with significant control on 1 June 2021
01 Jun 2021 AP01 Appointment of Seung Wook Jeong as a director on 1 June 2021
01 Jun 2021 PSC07 Cessation of North East Technology (Gp) Limited as a person with significant control on 1 June 2021
23 Apr 2021 RP04CS01 Second filing of Confirmation Statement dated 9 October 2020
06 Apr 2021 RP04CS01 Second filing of Confirmation Statement dated 9 October 2020
22 Oct 2020 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Re-loan agreement 17/06/2020
  • RES10 ‐ Resolution of allotment of securities
19 Oct 2020 CS01 09/10/20 Statement of Capital gbp 235.729
  • ANNOTATION Clarification a second filed CS01 statement of capital & shareholder information was registered on 06/04/21
  • ANNOTATION Clarification a second filed CS01 statement of capital & shareholder information was registered on 23/04/21
22 Sep 2020 AA Total exemption full accounts made up to 31 July 2020
15 Jul 2020 AP01 Appointment of Mr William Taninhill Blair as a director on 15 July 2020
11 Jun 2020 TM01 Termination of appointment of Samuel Cameron Williams as a director on 28 May 2020
23 Oct 2019 AA Total exemption full accounts made up to 31 July 2019
09 Oct 2019 CS01 Confirmation statement made on 9 October 2019 with updates